chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia
Clinical narrative: fever; headache feels like a migraine; light-headed/dizzy; pain continues and left arm; nausea at times; lack of desire to eat at times; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207), via an unspecified route of administration in the left arm on 19Mar2021 at 10:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included ascorbic acid (VITAMIN C) and Prednisone (MANUFACTURER UNKNOWN) and Silver (COLLOIDAL SILVER) for unknown indication from unknown date. The patient was allergic to codeine. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 21Mar2021 at 15:00 patient experienced fever, Day 5 still fever most days over 100, headache feels like a migraine, light-headed and dizzy, pain continued and left arm, lack of desire to eat at times. It was reported he missed work for 2 days and unable to drive due to headache and light-headedness. Treatment was taken for the reported events and included ibuprofen for fever and meclizine for dizzy. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events fever, headache, dizzy, pain in arm, nausea and appetite lost was not recovered.   No follow-up attempts possible. No further information expected.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Decreased appetite, Dizziness, Headache, Nausea
Clinical narrative: fever; headache feels like a migraine; light-headed/dizzy; pain continues and left arm; nausea at times; lack of desire to eat at times; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207), via an unspecified route of administration in the left arm on 19Mar2021 at 10:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included ascorbic acid (VITAMIN C) and Prednisone (MANUFACTURER UNKNOWN) and Silver (COLLOIDAL SILVER) for unknown indication from unknown date. The patient was allergic to codeine. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 21Mar2021 at 15:00 patient experienced fever, Day 5 still fever most days over 100, headache feels like a migraine, light-headed and dizzy, pain continued and left arm, lack of desire to eat at times. It was reported he missed work for 2 days and unable to drive due to headache and light-headedness. Treatment was taken for the reported events and included ibuprofen for fever and meclizine for dizzy. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events fever, headache, dizzy, pain in arm, nausea and appetite lost was not recovered.   No follow-up attempts possible. No further information expected.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: fever; headache feels like a migraine; light-headed/dizzy; pain continues and left arm; nausea at times; lack of desire to eat at times; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207), via an unspecified route of administration in the left arm on 19Mar2021 at 10:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included ascorbic acid (VITAMIN C) and Prednisone (MANUFACTURER UNKNOWN) and Silver (COLLOIDAL SILVER) for unknown indication from unknown date. The patient was allergic to codeine. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 21Mar2021 at 15:00 patient experienced fever, Day 5 still fever most days over 100, headache feels like a migraine, light-headed and dizzy, pain continued and left arm, lack of desire to eat at times. It was reported he missed work for 2 days and unable to drive due to headache and light-headedness. Treatment was taken for the reported events and included ibuprofen for fever and meclizine for dizzy. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events fever, headache, dizzy, pain in arm, nausea and appetite lost was not recovered.   No follow-up attempts possible. No further information expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Asthenia, Breast swelling, Burning sensation, Confusional state
Clinical narrative: Weakness; Warm heating sensation in body mostly in breast; pressure between shoulder blades; Swollen arms; Blue/ grey spots on upper thigh; Heaviness in arms; Pressure in head; Tingling sensation in head; Numbness in left arm fingers; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in left arm on 03Mar2021 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9264) via an unspecified route of administration in left arm on 08Feb2021, as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 04Mar2021, the patient experienced weakness, warm heating sensation in body mostly in breast, pressure between shoulder blades, swollen arms, blue/ grey spots on upper thigh, heaviness in arms, pressure and tingling sensation in head, and numbness in left arm fingers. It was reported that patient was seen by primary care provider, emergency room department, infectious disease specialist and rheumatologist. No answers to what was happening, other than this could be a reaction to the vaccine. The patient reported that, it was 22 days since received second Pfizer shot and was still in pain, she felt like a different person and not getting any help or find answers to what was going on. The events resulted in doctor or other healthcare professional office/clinic visit/ emergency visit. The patient did not receive any treatment for the events. The clinical outcome of events weakness, sensation of warmth, sensation of pressure, swollen arm, spot pigmented, heaviness in arm, head pressure, tingling sensation and numbness in fingers was not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Laboratory test normal, Pain, Peripheral swelling, Skin discolouration
Clinical narrative: Weakness; Warm heating sensation in body mostly in breast; pressure between shoulder blades; Swollen arms; Blue/ grey spots on upper thigh; Heaviness in arms; Pressure in head; Tingling sensation in head; Numbness in left arm fingers; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in left arm on 03Mar2021 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9264) via an unspecified route of administration in left arm on 08Feb2021, as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 04Mar2021, the patient experienced weakness, warm heating sensation in body mostly in breast, pressure between shoulder blades, swollen arms, blue/ grey spots on upper thigh, heaviness in arms, pressure and tingling sensation in head, and numbness in left arm fingers. It was reported that patient was seen by primary care provider, emergency room department, infectious disease specialist and rheumatologist. No answers to what was happening, other than this could be a reaction to the vaccine. The patient reported that, it was 22 days since received second Pfizer shot and was still in pain, she felt like a different person and not getting any help or find answers to what was going on. The events resulted in doctor or other healthcare professional office/clinic visit/ emergency visit. The patient did not receive any treatment for the events. The clinical outcome of events weakness, sensation of warmth, sensation of pressure, swollen arm, spot pigmented, heaviness in arm, head pressure, tingling sensation and numbness in fingers was not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Swelling, Swelling face
Clinical narrative: Weakness; Warm heating sensation in body mostly in breast; pressure between shoulder blades; Swollen arms; Blue/ grey spots on upper thigh; Heaviness in arms; Pressure in head; Tingling sensation in head; Numbness in left arm fingers; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in left arm on 03Mar2021 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9264) via an unspecified route of administration in left arm on 08Feb2021, as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 04Mar2021, the patient experienced weakness, warm heating sensation in body mostly in breast, pressure between shoulder blades, swollen arms, blue/ grey spots on upper thigh, heaviness in arms, pressure and tingling sensation in head, and numbness in left arm fingers. It was reported that patient was seen by primary care provider, emergency room department, infectious disease specialist and rheumatologist. No answers to what was happening, other than this could be a reaction to the vaccine. The patient reported that, it was 22 days since received second Pfizer shot and was still in pain, she felt like a different person and not getting any help or find answers to what was going on. The events resulted in doctor or other healthcare professional office/clinic visit/ emergency visit. The patient did not receive any treatment for the events. The clinical outcome of events weakness, sensation of warmth, sensation of pressure, swollen arm, spot pigmented, heaviness in arm, head pressure, tingling sensation and numbness in fingers was not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Illness, Pain, Pyrexia, Renal pain
Clinical narrative: Weakness; Warm heating sensation in body mostly in breast; pressure between shoulder blades; Swollen arms; Blue/ grey spots on upper thigh; Heaviness in arms; Pressure in head; Tingling sensation in head; Numbness in left arm fingers; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in left arm on 03Mar2021 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9264) via an unspecified route of administration in left arm on 08Feb2021, as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 04Mar2021, the patient experienced weakness, warm heating sensation in body mostly in breast, pressure between shoulder blades, swollen arms, blue/ grey spots on upper thigh, heaviness in arms, pressure and tingling sensation in head, and numbness in left arm fingers. It was reported that patient was seen by primary care provider, emergency room department, infectious disease specialist and rheumatologist. No answers to what was happening, other than this could be a reaction to the vaccine. The patient reported that, it was 22 days since received second Pfizer shot and was still in pain, she felt like a different person and not getting any help or find answers to what was going on. The events resulted in doctor or other healthcare professional office/clinic visit/ emergency visit. The patient did not receive any treatment for the events. The clinical outcome of events weakness, sensation of warmth, sensation of pressure, swollen arm, spot pigmented, heaviness in arm, head pressure, tingling sensation and numbness in fingers was not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Discomfort, Feeling hot, Head discomfort, Hypoaesthesia
Clinical narrative: Weakness; Warm heating sensation in body mostly in breast; pressure between shoulder blades; Swollen arms; Blue/ grey spots on upper thigh; Heaviness in arms; Pressure in head; Tingling sensation in head; Numbness in left arm fingers; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in left arm on 03Mar2021 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9264) via an unspecified route of administration in left arm on 08Feb2021, as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 04Mar2021, the patient experienced weakness, warm heating sensation in body mostly in breast, pressure between shoulder blades, swollen arms, blue/ grey spots on upper thigh, heaviness in arms, pressure and tingling sensation in head, and numbness in left arm fingers. It was reported that patient was seen by primary care provider, emergency room department, infectious disease specialist and rheumatologist. No answers to what was happening, other than this could be a reaction to the vaccine. The patient reported that, it was 22 days since received second Pfizer shot and was still in pain, she felt like a different person and not getting any help or find answers to what was going on. The events resulted in doctor or other healthcare professional office/clinic visit/ emergency visit. The patient did not receive any treatment for the events. The clinical outcome of events weakness, sensation of warmth, sensation of pressure, swollen arm, spot pigmented, heaviness in arm, head pressure, tingling sensation and numbness in fingers was not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Limb discomfort, Paraesthesia, Peripheral swelling, Pigmentation disorder
Clinical narrative: Weakness; Warm heating sensation in body mostly in breast; pressure between shoulder blades; Swollen arms; Blue/ grey spots on upper thigh; Heaviness in arms; Pressure in head; Tingling sensation in head; Numbness in left arm fingers; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in left arm on 03Mar2021 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9264) via an unspecified route of administration in left arm on 08Feb2021, as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 04Mar2021, the patient experienced weakness, warm heating sensation in body mostly in breast, pressure between shoulder blades, swollen arms, blue/ grey spots on upper thigh, heaviness in arms, pressure and tingling sensation in head, and numbness in left arm fingers. It was reported that patient was seen by primary care provider, emergency room department, infectious disease specialist and rheumatologist. No answers to what was happening, other than this could be a reaction to the vaccine. The patient reported that, it was 22 days since received second Pfizer shot and was still in pain, she felt like a different person and not getting any help or find answers to what was going on. The events resulted in doctor or other healthcare professional office/clinic visit/ emergency visit. The patient did not receive any treatment for the events. The clinical outcome of events weakness, sensation of warmth, sensation of pressure, swollen arm, spot pigmented, heaviness in arm, head pressure, tingling sensation and numbness in fingers was not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Altered state of consciousness, Amnesia, Blindness, Chills, Computerised tomogram normal
Clinical narrative: weird feeling in her head; headache; she thought she would pass out; This is a spontaneous report from a contactable consumer or other non hcp (patient). An 83 year old elderly female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EN6201, expiration date unspecified), via an unspecified route of administration on 20Feb2021 as DOSE 2, SINGLE for covid-19 immunization (82 year when vaccinated). Previously the patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EL9263, expiration date unspecified), via an unspecified route of administration on 29Jan2021 as DOSE 1, SINGLE for covid-19 immunization. Medical history included patient catheterized reason unspecified. The patient's concomitant medications were not reported. On an unknown date, the patient came home and experienced weird feeling in her head with headache and she thought she would pass out. Patient stated that she had a minimal reaction to the second dose. She had no problems the day she got it other than a weird feeling in her head later that day. It was a strange, weird feeling with a headache. She says for about 5 minutes, she thought she would pass out. She laid back in her chair and then she felt better. She said what else was she going to do, she would probably die if she didn't get the vaccine. The patient also had 2 CT scans and 2 MRI but the results are unknown at the time of report. The outcome of the events was reported as unknown at the time of report.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Confusional state, Electroencephalogram normal, Fall, Fear, Feeling abnormal
Clinical narrative: weird feeling in her head; headache; she thought she would pass out; This is a spontaneous report from a contactable consumer or other non hcp (patient). An 83 year old elderly female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EN6201, expiration date unspecified), via an unspecified route of administration on 20Feb2021 as DOSE 2, SINGLE for covid-19 immunization (82 year when vaccinated). Previously the patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EL9263, expiration date unspecified), via an unspecified route of administration on 29Jan2021 as DOSE 1, SINGLE for covid-19 immunization. Medical history included patient catheterized reason unspecified. The patient's concomitant medications were not reported. On an unknown date, the patient came home and experienced weird feeling in her head with headache and she thought she would pass out. Patient stated that she had a minimal reaction to the second dose. She had no problems the day she got it other than a weird feeling in her head later that day. It was a strange, weird feeling with a headache. She says for about 5 minutes, she thought she would pass out. She laid back in her chair and then she felt better. She said what else was she going to do, she would probably die if she didn't get the vaccine. The patient also had 2 CT scans and 2 MRI but the results are unknown at the time of report. The outcome of the events was reported as unknown at the time of report.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Feeling cold, Hyperhidrosis, Limb injury, Loss of consciousness, Magnetic resonance imaging normal
Clinical narrative: weird feeling in her head; headache; she thought she would pass out; This is a spontaneous report from a contactable consumer or other non hcp (patient). An 83 year old elderly female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EN6201, expiration date unspecified), via an unspecified route of administration on 20Feb2021 as DOSE 2, SINGLE for covid-19 immunization (82 year when vaccinated). Previously the patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EL9263, expiration date unspecified), via an unspecified route of administration on 29Jan2021 as DOSE 1, SINGLE for covid-19 immunization. Medical history included patient catheterized reason unspecified. The patient's concomitant medications were not reported. On an unknown date, the patient came home and experienced weird feeling in her head with headache and she thought she would pass out. Patient stated that she had a minimal reaction to the second dose. She had no problems the day she got it other than a weird feeling in her head later that day. It was a strange, weird feeling with a headache. She says for about 5 minutes, she thought she would pass out. She laid back in her chair and then she felt better. She said what else was she going to do, she would probably die if she didn't get the vaccine. The patient also had 2 CT scans and 2 MRI but the results are unknown at the time of report. The outcome of the events was reported as unknown at the time of report.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mobility decreased, Neurological symptom, Pain, Pyrexia, Scan with contrast
Clinical narrative: weird feeling in her head; headache; she thought she would pass out; This is a spontaneous report from a contactable consumer or other non hcp (patient). An 83 year old elderly female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EN6201, expiration date unspecified), via an unspecified route of administration on 20Feb2021 as DOSE 2, SINGLE for covid-19 immunization (82 year when vaccinated). Previously the patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EL9263, expiration date unspecified), via an unspecified route of administration on 29Jan2021 as DOSE 1, SINGLE for covid-19 immunization. Medical history included patient catheterized reason unspecified. The patient's concomitant medications were not reported. On an unknown date, the patient came home and experienced weird feeling in her head with headache and she thought she would pass out. Patient stated that she had a minimal reaction to the second dose. She had no problems the day she got it other than a weird feeling in her head later that day. It was a strange, weird feeling with a headache. She says for about 5 minutes, she thought she would pass out. She laid back in her chair and then she felt better. She said what else was she going to do, she would probably die if she didn't get the vaccine. The patient also had 2 CT scans and 2 MRI but the results are unknown at the time of report. The outcome of the events was reported as unknown at the time of report.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram, Feeling abnormal, Headache, Magnetic resonance imaging, Presyncope
Clinical narrative: weird feeling in her head; headache; she thought she would pass out; This is a spontaneous report from a contactable consumer or other non hcp (patient). An 83 year old elderly female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EN6201, expiration date unspecified), via an unspecified route of administration on 20Feb2021 as DOSE 2, SINGLE for covid-19 immunization (82 year when vaccinated). Previously the patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EL9263, expiration date unspecified), via an unspecified route of administration on 29Jan2021 as DOSE 1, SINGLE for covid-19 immunization. Medical history included patient catheterized reason unspecified. The patient's concomitant medications were not reported. On an unknown date, the patient came home and experienced weird feeling in her head with headache and she thought she would pass out. Patient stated that she had a minimal reaction to the second dose. She had no problems the day she got it other than a weird feeling in her head later that day. It was a strange, weird feeling with a headache. She says for about 5 minutes, she thought she would pass out. She laid back in her chair and then she felt better. She said what else was she going to do, she would probably die if she didn't get the vaccine. The patient also had 2 CT scans and 2 MRI but the results are unknown at the time of report. The outcome of the events was reported as unknown at the time of report.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cerebrovascular accident, Hypoacusis, Loss of consciousness
Clinical narrative: weird feeling in her head; headache; she thought she would pass out; This is a spontaneous report from a contactable consumer or other non hcp (patient). An 83 year old elderly female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EN6201, expiration date unspecified), via an unspecified route of administration on 20Feb2021 as DOSE 2, SINGLE for covid-19 immunization (82 year when vaccinated). Previously the patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EL9263, expiration date unspecified), via an unspecified route of administration on 29Jan2021 as DOSE 1, SINGLE for covid-19 immunization. Medical history included patient catheterized reason unspecified. The patient's concomitant medications were not reported. On an unknown date, the patient came home and experienced weird feeling in her head with headache and she thought she would pass out. Patient stated that she had a minimal reaction to the second dose. She had no problems the day she got it other than a weird feeling in her head later that day. It was a strange, weird feeling with a headache. She says for about 5 minutes, she thought she would pass out. She laid back in her chair and then she felt better. She said what else was she going to do, she would probably die if she didn't get the vaccine. The patient also had 2 CT scans and 2 MRI but the results are unknown at the time of report. The outcome of the events was reported as unknown at the time of report.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eyelid rash, Rash
Clinical narrative: rash on throat, extended to face (left eye); This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in the left arm on 02Mar2021 at 11:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient medical history included rheumatoid arthritis. Concomitant medication included methotrexate (MANUFACTURER UNKNOWN) received within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot no: UNKNOWN) via an unspecified route on 10Feb2021 at 11:30 (at the age of 39-Years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies to medications, food, or other products. On 04Mar2021 evening a rash started developing near patient throat and it became prominent on March5 and subsequent days of it getting worse. It has been 20 days and the rash has not subsided despite applying local corticosteroid cream. Furthermore, it has extended to face (left eye). Additionally, patient had not changed food intake, or used any new facial creams. Patient was also using hypoallergenic creams. Patient was worried and showed rash to a doctor who suspects that this could be an allergic reaction to the vaccination The events had resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with corticosteroid and hypoallergenic creams. The clinical outcome of rash was not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: rash on throat, extended to face (left eye); This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in the left arm on 02Mar2021 at 11:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient medical history included rheumatoid arthritis. Concomitant medication included methotrexate (MANUFACTURER UNKNOWN) received within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot no: UNKNOWN) via an unspecified route on 10Feb2021 at 11:30 (at the age of 39-Years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies to medications, food, or other products. On 04Mar2021 evening a rash started developing near patient throat and it became prominent on March5 and subsequent days of it getting worse. It has been 20 days and the rash has not subsided despite applying local corticosteroid cream. Furthermore, it has extended to face (left eye). Additionally, patient had not changed food intake, or used any new facial creams. Patient was also using hypoallergenic creams. Patient was worried and showed rash to a doctor who suspects that this could be an allergic reaction to the vaccination The events had resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with corticosteroid and hypoallergenic creams. The clinical outcome of rash was not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Numbness and tingling in both arms, from shoulders to fingertips; Numbness and tingling in both arms, from shoulders to fingertips; This is a spontaneous report received from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER 8733) via unspecified route of administration in right arm on 25Mar2021 at 16:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included blood clot in left leg due to twin pregnancy in 2019 and the patients son was born with rare brain malformation in 2019. The known allergies were reported as no. The concomitant medications were reported as no. The patient did not receive other vaccine in four weeks prior to COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 25Mar2021 at 16:15, the patient experienced numbness and tingling in both arms, from shoulders to fingertips. It started about 10 minutes after the vaccine was given (it still remained after 2.5 hours, at the time of report). The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No treatment was received for the events. The clinical outcome of numbness and tingling in both arms, from shoulders to fingertips was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram, IIIrd nerve paralysis
Clinical narrative: Sandy eye after first dose; Headaches; This is a spontaneous report from a contactable consumer (patient). A 73-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EL9269), via intramuscular route, administered in left arm on 05Feb2021 as DOSE 1, 0.3 ML SINGLE DOSE for covid-19 immunisation. The patient's medical history included heart attack in 2013 and stent put in (preventative for plaque build up in veins). Patient did not have cardiovascular disease; he just had a blockage at one time. Concomitant medication(s) included simvastatin 20mg once daily from 2013, in low dose to prevent plague build up. On 10Feb2021, 5 days later, the patient experienced sandy eye after first dose and headache. The sandy eye worsened. He went to his eye doctor and he was not sure. He did not mention any correlation with the COVID shot, then he said he did not see any foreign object. Headaches, he still gets periodically. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. There were no additional vaccines administered on same date of the Pfizer suspect. The outcome of the event foreign body sensation in eyes was not recovered; headache was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram, Eyelid ptosis, Foreign body sensation in eyes, Headache, IIIrd nerve paralysis
Clinical narrative: Sandy eye after first dose; Headaches; This is a spontaneous report from a contactable consumer (patient). A 73-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EL9269), via intramuscular route, administered in left arm on 05Feb2021 as DOSE 1, 0.3 ML SINGLE DOSE for covid-19 immunisation. The patient's medical history included heart attack in 2013 and stent put in (preventative for plaque build up in veins). Patient did not have cardiovascular disease; he just had a blockage at one time. Concomitant medication(s) included simvastatin 20mg once daily from 2013, in low dose to prevent plague build up. On 10Feb2021, 5 days later, the patient experienced sandy eye after first dose and headache. The sandy eye worsened. He went to his eye doctor and he was not sure. He did not mention any correlation with the COVID shot, then he said he did not see any foreign object. Headaches, he still gets periodically. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. There were no additional vaccines administered on same date of the Pfizer suspect. The outcome of the event foreign body sensation in eyes was not recovered; headache was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vision blurred
Clinical narrative: Sandy eye after first dose; Headaches; This is a spontaneous report from a contactable consumer (patient). A 73-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EL9269), via intramuscular route, administered in left arm on 05Feb2021 as DOSE 1, 0.3 ML SINGLE DOSE for covid-19 immunisation. The patient's medical history included heart attack in 2013 and stent put in (preventative for plaque build up in veins). Patient did not have cardiovascular disease; he just had a blockage at one time. Concomitant medication(s) included simvastatin 20mg once daily from 2013, in low dose to prevent plague build up. On 10Feb2021, 5 days later, the patient experienced sandy eye after first dose and headache. The sandy eye worsened. He went to his eye doctor and he was not sure. He did not mention any correlation with the COVID shot, then he said he did not see any foreign object. Headaches, he still gets periodically. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. There were no additional vaccines administered on same date of the Pfizer suspect. The outcome of the event foreign body sensation in eyes was not recovered; headache was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Foreign body sensation in eyes, Headache
Clinical narrative: Sandy eye after first dose; Headaches; This is a spontaneous report from a contactable consumer (patient). A 73-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EL9269), via intramuscular route, administered in left arm on 05Feb2021 as DOSE 1, 0.3 ML SINGLE DOSE for covid-19 immunisation. The patient's medical history included heart attack in 2013 and stent put in (preventative for plaque build up in veins). Patient did not have cardiovascular disease; he just had a blockage at one time. Concomitant medication(s) included simvastatin 20mg once daily from 2013, in low dose to prevent plague build up. On 10Feb2021, 5 days later, the patient experienced sandy eye after first dose and headache. The sandy eye worsened. He went to his eye doctor and he was not sure. He did not mention any correlation with the COVID shot, then he said he did not see any foreign object. Headaches, he still gets periodically. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. There were no additional vaccines administered on same date of the Pfizer suspect. The outcome of the event foreign body sensation in eyes was not recovered; headache was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle twitching, Oral herpes, Paraesthesia
Clinical narrative: Tingling; Tingling of face followed by twitching; Hands and feet had pins & needle sensations; injection site pain; swelling; redness; joint pain in hands; muscle aches; chills; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number; EL9266) via an unspecified route of administration in left arm on 07Mar2021 at 13:30 (at the age of 66-year-old) as single dose for COVID-19 immunisation. Medical history included osteoporosis and the patient was allergic to MRI contrast dye, hydrocodone, keflex, sulfides. The concomitant medications included fish oil (MANUFACTURER UNKNOWN), cholecalciferol (CALCIUM SUPPLEMENT), calcium carbonate (CALCIUM SUPPLEMENT), ascorbic acid (VITAMIN C), tocopherol (VITAMIN E) and ubidecarenone (CoQ10) all for unknown indications and from an unknown date. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 14Mar2021 at 01:00, patient experienced tingling of face followed by twitching, hands and feet had pins & needle sensations, injection site pain, injection site swelling, injection site redness, joint pain in hands, muscle aches, and chills. The patient did not receive any treatment for the adverse event. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event tingling of face followed by twitching, hands and feet had pins & needle sensations, injection site pain, injection site swelling, injection site redness, joint pain in hands, muscle aches, and chills were recovering at the time of report.     No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Tingling; Tingling of face followed by twitching; Hands and feet had pins & needle sensations; injection site pain; swelling; redness; joint pain in hands; muscle aches; chills; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number; EL9266) via an unspecified route of administration in left arm on 07Mar2021 at 13:30 (at the age of 66-year-old) as single dose for COVID-19 immunisation. Medical history included osteoporosis and the patient was allergic to MRI contrast dye, hydrocodone, keflex, sulfides. The concomitant medications included fish oil (MANUFACTURER UNKNOWN), cholecalciferol (CALCIUM SUPPLEMENT), calcium carbonate (CALCIUM SUPPLEMENT), ascorbic acid (VITAMIN C), tocopherol (VITAMIN E) and ubidecarenone (CoQ10) all for unknown indications and from an unknown date. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 14Mar2021 at 01:00, patient experienced tingling of face followed by twitching, hands and feet had pins & needle sensations, injection site pain, injection site swelling, injection site redness, joint pain in hands, muscle aches, and chills. The patient did not receive any treatment for the adverse event. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event tingling of face followed by twitching, hands and feet had pins & needle sensations, injection site pain, injection site swelling, injection site redness, joint pain in hands, muscle aches, and chills were recovering at the time of report.     No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle twitching, Myalgia, Paraesthesia
Clinical narrative: Tingling; Tingling of face followed by twitching; Hands and feet had pins & needle sensations; injection site pain; swelling; redness; joint pain in hands; muscle aches; chills; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number; EL9266) via an unspecified route of administration in left arm on 07Mar2021 at 13:30 (at the age of 66-year-old) as single dose for COVID-19 immunisation. Medical history included osteoporosis and the patient was allergic to MRI contrast dye, hydrocodone, keflex, sulfides. The concomitant medications included fish oil (MANUFACTURER UNKNOWN), cholecalciferol (CALCIUM SUPPLEMENT), calcium carbonate (CALCIUM SUPPLEMENT), ascorbic acid (VITAMIN C), tocopherol (VITAMIN E) and ubidecarenone (CoQ10) all for unknown indications and from an unknown date. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 14Mar2021 at 01:00, patient experienced tingling of face followed by twitching, hands and feet had pins & needle sensations, injection site pain, injection site swelling, injection site redness, joint pain in hands, muscle aches, and chills. The patient did not receive any treatment for the adverse event. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event tingling of face followed by twitching, hands and feet had pins & needle sensations, injection site pain, injection site swelling, injection site redness, joint pain in hands, muscle aches, and chills were recovering at the time of report.     No follow-up attempts are needed. No further information is expected.